02445cam a22003013u 450000100060000000300070000600500170001300600020003000700050003200800410003704000110007804100170008905000070010610000700011324500680018326400510025130000470030233600260034933700260037533800360040150000310043750802030046852013460067153400450201765300210206285600430208399900170212647766UtSlPG20260610134110.0mcr n260607r2014||||utu|||||o|||||||||||||| d  aUtSlPG 7aen2iso639-1 4aRM1 aCouncil on Pharmacy and Chemistryq(American Medical Association)14aThe Propaganda for Reform in Proprietary Medicines, Vol. 1 of 2 1aSalt Lake City, UT :bProject Gutenberg,c2014  a1 online resource :bmultiple file formats  atextbtxt2rdacontent  acomputerbc2rdamedia  aonline resourcebcr2rdacarrier  aRelease date is 2014-12-24  aProduced by David Edwards, Thiers Halliwell and the Online
Distributed Proofreading Team at http://www.pgdp.net (This
file was produced from images generously made available
by The Internet Archive)  a"The Propaganda for Reform in Proprietary Medicines, Vol. 1 of 2" is a scientific publication likely written in the early 20th century. The work is a compilation of reports and analyses from the Journal of the American Medical Association and focuses on the evaluation of various proprietary and patent medicines that were prevalent at the time. It serves as a critical examination of the questionable ethics and efficacy of such medicines, often exposing misinformation and deceptive marketing tactics aimed at both the public and healthcare professionals.  The opening of this volume introduces the purpose and structure of the publication, highlighting its establishment as a response to ongoing concerns within the medical community regarding the safety and effectiveness of proprietary medicines. It outlines the Council’s intention to provide clear distinctions between ethical medications and those deemed quackery or harmful. This portion includes various reports that analyze specific products, revealing inconsistencies in their claimed ingredients and therapeutic effects, while emphasizing the potential dangers of misleading advertisements. The text's scholarly tone and systematic approach suggest a commitment to promoting transparency and reform in the pharmaceutical industry. (This is an automatically generated summary.)  nOriginal publication data not identified  aPatent medicines40uhttps://www.gutenberg.org/ebooks/47766  c88605d88605